Jump to content

Levobetaxolol

From Wikipedia, the free encyclopedia

Levobetaxolol
Clinical data
Trade namesBetaxon
Other namesAL-1577A
AHFS/Drugs.comMicromedex Detailed Consumer Information
Routes of
administration
Ophthalmic
ATC code
  • None
Legal status
Legal status
Pharmacokinetic data
Elimination half-life20 hours
Identifiers
  • (2S)-1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan)-2-ylamino)propan-2-ol
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC18H29NO3
Molar mass307.434 g·mol−1
3D model (JSmol)
  • O(C[C@H](CNC(C)C)O)C1=CC=C(CCOCC2CC2)C=C1
  • InChI=1S/C18H29NO3/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3/t17-/m0/s1
  • Key:NWIUTZDMDHAVTP-KRWDZBQOSA-N
  • Key:CHDPSNLJFOQTRK-LMOVPXPDSA-N

Levobetaxolol, sold under the brand name Betaxon, is a medication used to lower the pressure in the eye in treating conditions such as glaucoma.[1] It is used as the salt levobetaxolol hydrochloride.[1] Levobetaxolol is a beta-adrenergic receptor inhibitor (beta blocker).[1]

Medical uses

[edit]

Levobetaxolol is indicated for lowering intraocular pressure in people with chronic open-angle glaucoma or ocular hypertension.[1][2]

Contraindications

[edit]

Levobetaxolol is contraindicated in people with sinus bradycardia, atrioventricular block, cardiogenic shock, or overt cardiac failure.[1]

History

[edit]

Levobetaxolol was developed in the 1980s.[2] It was approved by the US Food and Drug Administration in 2000.[3][4]

References

[edit]
  1. 1 2 3 4 5 6 https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21114lbl.pdf
  2. 1 2 Quaranta L, Turano R, Pizzolante T (June 2007). "Levobetaxolol hydrochloride: a review of its pharmacology and use in the treatment of chronic open-angle glaucoma and ocular hypertension". Clinical Ophthalmology. 1 (2): 93–7. PMC 2704505. PMID 19668496.
  3. ↑ "Drug Approval Package: Betaxon (Levobetaxolol Hydrochloride) Ophthalmic Suspension". U.S. Food and Drug Administration (FDA). Retrieved 9 November 2026.
  4. ↑ "Betaxon New FDA Drug Approval". CenterWatch. Retrieved 11 April 2019.